Trial Studied treatment Control Patients Size Study type Results NCT

Cardiovascular prevention - weight-loss drugs in overweight or obese patients

AUDITOR ongoing rimonabantplaceboNA
CRESCENDO, 2010rimonabantplacebo18695 (9381/9314) Confirmatory NCT00263042
RIO europe 20mg, 2005rimonabant 20mgplacebo904 (599/305)
Rio-lipid 20 mg, 2005rimonabant 20mgplacebo688 (346/342)
RIO-North America 20 mg, 2006rimonabant 20mgplacebo1829 (1222/607) NCT00029861
RIO europe (20 vs 5 mg), 2005rimonabant 20mgrimonabant 5mg1202 (599/603)
RIO europe 5mg, 2005rimonabant 5mgplacebo908 (603/305) Exploratory